The FDA has approved AstraZeneca and Daiichi Sankyo’s Datroway (datopotamab deruxtecan-dlnk) to treat unresectable or ...

British drug maker AstraZeneca Plc (AZN.L, AZN) and Daiichi Sankyo (DSKYF.PK) announced Monday that their Datroway (datopotamab ...

Approval is based on results from the TROPION-Breast01 Phase III trial, in which Datroway demonstrated a significant reduction in the risk of disease progression or death in patients with previously ...

Hospital chaplains help patients and families, whether religious, atheist, agnostic, or "nothing in particular," find meaning ...

A breast cancer survivor received an unexpected gift this week from Tina's Angels, a national organization dedicated to creating lasting memories for families a ...

Tokyo: Daichi Sankyo has announced that DATROWAY (datopotamab deruxtecan-dlnk) has been approved in the U.S. for the ...

AstraZeneca (AZ) and Daiichi Sankyo’s Datroway (datopotamab deruxtecan-dlnk) has been approved by the US Food and Drug ...

Ameena Westwood, 53, started getting 'bad cough and shortness of breath' before being told her breast cancer had 'spread to ...

A report from Macmillan estimated a record 3.5m in the UK are living with cancer in 2025, including 98,000 in Northern ...

Cancer treatment is undergoing a revolution, and immunotherapy is leading the charge. Unlike traditional methods like ...

Cancer is now the second leading cause of death worldwide, and rates are climbing-especially in younger adults. Breast, ...

Expected to begin in 2027, the trials will involve human patients, and the researchers are working to obtain the necessary ...